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GABAB receptors are the G-protein-coupled receptors for GABA, the main inhibitory neurotransmitter in the brain. Two receptor
subtypes, GABAB(1a,2) and GABAB(1b,2), are formed by the assembly of GABAB1a and GABAB1b subunits with GABAB2 subunits. The
GABAB1b subunit is a shorter isoform of the GABAB1a subunit lacking two N-terminal protein interaction motifs, the sushi domains.
SelectivelyGABAB1aprotein traffics into theaxonsof glutamatergicneurons,whereasboth theGABAB1a andGABAB1bproteins traffic into
the dendrites. The mechanism(s) and targeting signal(s) responsible for the selective trafficking of GABAB1a protein into axons are
unknown. Here, we provide evidence that the sushi domains are axonal targeting signals that redirect GABAB1a protein from its default
dendritic localization toaxons. Specifically,we showthatmutations in the sushidomainspreventingprotein interactionsprecludeaxonal
localization of GABAB1a. When fused to CD8, the sushi domains polarize this uniformly distributed protein to axons. Likewise, when
fused to mGluR1a the sushi domains redirect this somatodendritic protein to axons, showing that the sushi domains can override
dendritic targeting information in a heterologous protein. Cell surface expression of the sushi domains is not required for axonal
localization of GABAB1a. Altogether, our findings are consistent with the sushi domains functioning as axonal targeting signals by
interacting with axonally bound proteins along intracellular sorting pathways. Our data provide a mechanistic explanation for the
selective trafficking of GABAB(1a,2) receptors into axonswhile at the same time identifying awell defined axonal deliverymodule that can
be used as an experimental tool.
Introduction
GABAB receptors exert distinct regulatory effects on synaptic
transmission (Couve et al., 2000; Bowery et al., 2002; Ulrich and
Bettler, 2007). Presynaptic GABAB receptors inhibit the release of
GABA (autoreceptors) and other neurotransmitters (heterore-
ceptors), while postsynaptic GABAB receptors inhibit neuronal
excitability by activating K channels. Receptor subtypes are
based on the subunit isoforms GABAB1a and GABAB1b, both of
which combine with GABAB2 subunits to form two heteromeric
receptors, GABAB(1a,2) and GABAB(1b,2) (Marshall et al., 1999).
Most if not all neurons in the CNS coexpress GABAB(1a,2) and
GABAB(1b,2) receptors. The GABAB1a and GABAB1b subunit iso-
forms derive from the same gene by alternative promoter usage
and solely differ in their N-terminal ectodomains (Kaupmann et
al., 1997; Steiger et al., 2004). GABAB1a contains at its N terminus
two sushi domains (SDs) that are lacking in GABAB1b (Hawrot et
al., 1998). SDs, also known as complement control protein (CCP)
modules or short consensus repeats (SCR), are conserved protein
interactionmotifs present in proteins of the complement system,
in adhesion molecules and in G-protein-coupled receptors
(Morley andCampbell, 1984; Kirkitadze andBarlow, 2001; Grace
et al., 2004; Lehtinen et al., 2004; Perrin et al., 2006). The tertiary
structure of SDs is fixed by two intramolecular disulfide bridges
that are critical for interaction with other proteins (Soares and
Barlow, 2005). Consistent with their role as interaction motifs,
the SDs of GABAB1a recognize binding sites in neuronal mem-
branes (Tiao et al., 2008).
The individual functions of the GABAB1a and GABAB1b sub-
unit isoforms were dissected by comparing genetically modified
1a/ and 1b/ mice, which express either one or the other
isoform (Pe´rez-Garci et al., 2006; Shaban et al., 2006; Vigot et al.,
2006; Ulrich and Bettler, 2007; Ulrich et al., 2007; Guetg et al.,
2009). It was found that only GABAB(1a,2) receptors inhibit glu-
tamate release in response to endogenous GABA, while both
GABAB(1a,2) and GABAB(1b,2) receptors mediate postsynaptic in-
hibition. This is a consequence of a selective trafficking of
GABAB(1a,2) receptors into axons. Specifically, experiments with
organotypic slice cultures revealed that heterologously expressed
GABAB1a subunits traffic to axons and dendrites, while GABAB1b
subunits traffic to dendrites only (Vigot et al., 2006). The signals
and mechanisms leading to a somatodendritic expression of
GABAB1b subunits and a more uniform distribution of GABAB1a
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subunits are unknown. In general, polarized sorting of trans-
membrane proteins relies on signals in the targeted protein them-
selves (Craig and Banker, 1994; Winckler and Mellman, 1999).
Since the targeting location of the shorter GABAB(1b,2) receptor is
the somatodendritic compartment, this suggests that the longer
GABAB(1a,2) receptor also contains common dendritic targeting
signals in either the GABAB1a or the associated GABAB2 subunit.
This implies a mechanism that prevents a fraction of GABAB(1a,2)
receptors from trafficking to the default somatodendritic com-
partment and instead directs them to axons.
Here, we report that GABAB(1a,2) receptors are trafficked into
axons by the SDs, which function as axonal targeting signals
along intracellular sorting pathways. We discuss the mechanistic
and regulatory implications of our findings.
Materials andMethods
Mouse strains. Primary neuronal cultures were prepared from WT
BALB/c mice or 1a/, 1b/, and 2/mice that were strictly kept in
the BALB/c inbred background (Schuler et al., 2001; Gassmann et al.,
2004; Vigot et al., 2006). All animal experiments were subjected to insti-
tutional review and conducted in accordance with Swiss guidelines and
approved by the veterinary office of Basel-Stadt.
Generation of mutant proteins.Cloning ofMyc-tagged expression con-
structs was based on a strategy described earlier (Pagano et al., 2001).
Briefly, to allow detection of transiently expressed subunits, the intrinsic
signal peptides were replaced by 36 residues encoding themGluR5 signal
peptide MVLLLILSVLLLKEDVRGSAQS, followed by the Myc-tag,
TREQKLISEEDLTR [replaced residues: Myc-GB1a, 1-16 (Kaupmann et
al., 1997); Myc-GB1b, 1-29 (Kaupmann et al., 1997); Myc-mGluR1a,
1-20 (Masu et al., 1991); Myc-CD8, 1-21]. The mGluR5 signal peptide
was used because it is known to accurately release N-terminal epitope
tags (Ango et al., 1999). To generate Myc-GB1aCS, the four cysteine
residues of GABAB1a at positions 29, 95, 99, and 156 (Kaupmann et al.,
1997) were mutated to serine residues by site-directed mutagenesis of
thymine to adenine. To generate Myc-GB1aSD1 andMyc-GB1aSD2,
residues G28 to C95 or V96 to Q157 of Myc-GB1a were deleted. To gen-
erate Myc-SDs-mGluR1a, residues G17 to S134 of GABAB1a were intro-
duced after the Myc-tag in rat Myc-mGluR1a (mGluR1a was a gift from
R. M. Duvoisin, Oregon Health and Science University, Portland, OR).
To generate Myc-SDs-CD8, the residues G17 to S134 of GABAB1a were
introduced after the Myc-tag in Myc-CD8 (CD8was a gift from G. A.
Banker, Oregon Health and Science University, Portland, OR). Initially,
all constructs were subcloned into the cytomegalovirus-based eukaryotic
expression vector pCI (Promega) to confirm protein expression inHEK293
cells. Subsequently all constructs were shuttled into plasmid pMH4-SYN-1
for expression under control of the synapsin-1 promoter in cultured hip-
pocampal neurons gift fromT.G.Oertner (FriedrichMiescher Institute for
Biomedical Research, Basel, Switzerland) andK. Svoboda (HowardHughes
Medical Institute, Ashburn,VA). InGB1a-GFP andGB1b-GFP, the coding
sequence for GFP was cloned in frame at the C terminus of full-length
GABAB1a andGABAB1b (Kaupmann et al., 1997), leaving the cognate signal
peptides unaltered. All constructs were verified by sequencing.
Neuronal culture and transfection. Cultured hippocampal neurons
were prepared as described previously (Brewer et al., 1993; Goslin et al.,
1998). Briefly, embryonic day 16.5 mouse hippocampi were dissected,
digestedwith 0.25% trypsin inHank’s solution (Invitrogen) for 15min at
37°C, dissociated by trituration, and plated on glass coverslips coated
with 1mg/ml poly-L-lysine hydrobromide (Sigma) in 0.1 M borate buffer
(boric acid/sodium tetraborate). Neurons were seeded at low density
(100–150 cells/mm2) for endogenousGABAB1 labeling or at high den-
sity (750 cells/mm2) for transfection experiments or electrophysiolog-
ical recordings and then incubated at 37°C/5% CO2. Low-density
cultures were cultivated in HC-MEM medium [1 MEM with Glu-
tamax, 0.3% glucose (w/v), 10% horse serum, and 1% Pen/Strep] for the
first 4 h to allow neurons to attach. Subsequently, the coverslips were
transferred to a feeder layer of primary astrocytes in serum-free medium
[1MEMwith Glutamax, 0.3% glucose (w/v), and 1% Pen/Strep] sup-
plemented with 1% N2 (Invitrogen). Primary astrocytes were obtained
fromnewborn P0-P1 BALB/cmice. To prevent extensive proliferation of
astrocytes 5 M arabinoside (AraC, Sigma) was added to the culture
medium after 2 d. High-density cultures were grown in Neurobasal me-
dium supplemented with B27 (Invitrogen), 0.5 mM L-glutamine, and
50–100 g/ml Pen/Strep. In addition, 25 M glutamic acid was added to
the medium for the first 3 d. At DIV5, neurons were cotransfected with
the appropriate expression constructs and soluble RFP (pMH4-SYN-
tdimer2-RFP; gift from R. Tsien, University of California San Diego, La
Jolla, CA) using Lipofectamine 2000 transfection reagent (Invitrogen).
Electrophysiology.Hippocampal neurons were cultured for 2–3 weeks.
On the day of the experiment, coverslips were placed in an interface
chamber containing saline solution (140 mM NaCl, 3 mM KCl, 2.5 mM
CaCl2, 1.2 mM MgCl2, 11.1 mM glucose, 10 mM HEPES, pH 7.2) equili-
brated with 95%O2/5%CO2 at 30–32°C. Neurons were visualized using
infrared and differential interference contrast optics. Whole-cell patch-
clamp recordings were performed at 60 mV from the somata of neu-
rons to measure mEPSCs in the presence of tetrodotoxin (1 M) and
bicuculline (10 M). Patch electrodes (3 M) were filled with a solu-
tion containing the following: 140 mM Cs-gluconate, 10 mM HEPES, 10
mM phosphocreatine, 5 mMQX-314, 4 mMMg-ATP, 0.3 mMNa-GTP, at
pH 7.2 with Cs-OH and 285 mOsm. During the experiment drugs were
applied by superfusion into the recording chamber. GABAB receptors
were activated by baclofen (100 M) and inactivated by the selective
antagonist CGP54626 (1 M). Detection and analysis of mEPSCs was
performed byMiniAnalysis software (version 6.0.4, Synaptosoft). Exper-
iments with CHO cells expressing WT or mutant GABAB receptors to-
gether with Kir3.1/3.2 channels and EGFP (used as a transfection
marker) were performed at room temperature (RT) 2 d after transfection
with Lipofectamine 2000 (Invitrogen). As a negative control, CHO cells
expressing Kir3.1/3.2 channels and EGFP in the absence of GABAB re-
ceptors were used. Cells were continuously superfused with an extracel-
lular solution composed of the following (in mM): 145 NaCl, 2.5 KCl, 1
MgCl2, 2 CaCl2, 10 HEPES, 25 glucose; pH 7.3, 323 mOsm. Patch pi-
pettes were filled with an intracellular solution composed of the follow-
ing (in mM): 107.5 potassium gluconate, 32.5 KCl, 10 HEPES, 5 EGTA, 4
MgATP, 0.6 NaGTP, 10 Tris phosphocreatine; pH 7.2, 297 mOsm.
GABAB responses were evoked by application of baclofen (10 s) (Dittert
et al., 2006) and recorded with an Axopatch 200B patch-clamp amplifier.
The presence of Kir3.1/3.2 channels in transfected cells was confirmed in
voltage ramps from 150 mV to 30 mV in the presence of a high
extracellular potassium concentration (40 mM).
Immunocytochemistry. Neurons were fixed at DIV14 in 4% PFA/120
mM sucrose/PBS (137 mMNaCl, 8.5 mMNa2HPO4, 1.5 mM KH2PO4, 3.0
mMKCl) for 20min at RT, permeabilizedwith 0.25%TritonX-100 for 10
min, and blocked for 1 h with 10% normal goat serum (NGS) in PBS.
Primary antibodies were diluted in 10% NGS/PBS and incubated over-
night at 4°C. After washing with 1 PBS, neurons were incubated with
secondary antibodies diluted in 1% NGS/PBS for 1 h at RT. Primary
antibodieswere as follows: chicken anti-MAP2 (1:10,000; Abcam), rabbit
anti-GABAB1-C-term [1:500; Clone B17 (Kulik et al., 2002); gift from R.
Shigemoto (National Institute of Physiological Sciences, Okazaki, Ja-
pan)], mouse anti--tubulin (1:400; Sigma), mouse anti-Myc (1:500;
Roche). Secondary antibodies were as follows: Alexa goat anti-chicken
647, Alexa goat anti-rabbit 568, and Alexa goat anti-mouse 488 (1:500;
Molecular Probes). Neuronswere imaged in: 15%PVA (Celvol polyvinyl
alcohol Celanese Chemicals), 33% glycerol, and 0.1% sodium azide in
PBS, pH 7–7.4.
Microscopy. Immunolabeled neurons were viewed at room tempera-
ture on a Leica DM5000B fluorescence microscope. Glutamatergic neu-
rons were discriminated from GABAergic neurons by their extensively
branched spiny dendrites visualized by the RFP filling (Benson et al.,
1994; Obermair et al., 2003). Digital pictures were captured using Soft
Imaging System and AnalySIS software (F-View) and identically pro-
cessed with Adobe Photoshop (RGB input levels, brightness/contrast).
The filters used to detect secondary antibodies were as follows: L5-filter
for Alexa goat anti-mouse 488 (Myc antibody), Y5-filter for Alexa goat
anti-chicken 647 (MAP2 antibody), Y3-filter for RFP or Alexa goat anti-
rabbit 568 (polyclonal GABAB1 antibody). The ER-targeted GFP was
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from Clontech. Pictures were taken with each filter separately. Pictures
from the endogenous GABAB1 staining were captured using immersion
oil without autofluorescence (Leica Microsystems catalog #11513859)
and a 63 oil objective with 1.32 NA (HCX PL APO). Images to evaluate
the axonal versus dendritic distribution of heterologously expressed
GABAB protein were captured using a 20 air objective 0.7 NA (HC
PLAN APO).
Quantification of axonal versus dendritic distribution. The axon-to-
dendrite (A:D) ratio of endogenous GABAB1 protein was determined
using MetaMorph Imaging software. One-pixel-wide lines were traced
along representative axons and dendrites in the tubulin-stained images.
Next to each line, a rectangle was drawn for background subtraction. Subse-
quently, the lines and rectangles were transferred to the corresponding pic-
ture with GABAB1 immunostaining. Average
pixel intensities were determined along the
traced lines and in the background rectangles.
After background subtraction, the anti-
GABAB1 fluorescence intensitywas normalized
to the anti-tubulin fluorescence intensity in
axon and dendrites. The normalized data were
used to determine the A:D ratio. The A:D ratio
of Myc-tagged constructs was determined by
normalizing theMyc-labeling to the RFP label-
ing (Gu et al., 2003; Sampo et al., 2003). Cells
to be analyzed were selected using the soluble
RFP fill and only considered for quantifica-
tion if the RFP fluorescence was evenly dis-
tributed over the entire neuron, including
distal axons and dendrites. Cells expressing
constructs at very high levels were excluded
from analysis because such cells exhibit a less
polarized distribution of expressed proteins.
Seven to nineteen neurons from at least two
independent culture preparations for each
construct were analyzed. SPSS or GraphPad
PRISM software was used for statistical
analysis.
Reagents. TTX was from Latoxan. Baclofen and
CGP54626 were from Novartis Pharma. HEPES
was fromAppliChem (catalog #A1069.0100). All
other reagents were from Fluka/Sigma.
Results
Endogenous GABAB1a but not GABAB1b
subunits inhibit glutamate release
and localize to axons in cultured
hippocampal neurons
Pyramidal neurons typically make up 85–
90% of neurons in dissociated hippocam-
pal cultures (Goslin et al., 1998) and
potentially provide a simple experimental
system to study the targeting of trans-
fected GABAB1a and GABAB1b subunits in
glutamatergic neurons. We first investi-
gated whether cultured pyramidal neu-
rons preserve the selective association of
GABAB(1a,2) receptors with glutamatergic
terminals seen in hippocampal slices
(Vigot et al., 2006;Guetg et al., 2009). Spe-
cifically, we addressed whether functional
GABAB heteroreceptors are present in cul-
tured pyramidal neurons of 1b/ mice,
but absent in neurons of 1a/mice. Ac-
tivation of GABAB heteroreceptors by ba-
clofen, a GABAB receptor agonist, inhibits
the spontaneous release of glutamate and
as a result reduces the miniature EPSC
(mEPSC) frequency (Yamada et al., 1999; Tiao et al., 2008). We
found that baclofen strongly reduced the mEPSC frequencies in
wild-type (WT) and 1b/neurons, while baclofen onlymargin-
ally reduced the mEPSC frequency in 1a/ neurons (Fig.
1A,B). This confirms that functional GABAB heteroreceptors are
specifically lacking in cultured hippocampal neurons of 1a/
mice. Weak residual heteroreceptor activity in 1a/ mice in
response to high concentrations of baclofen was also observed in
acute hippocampal slices (Vigot et al., 2006; Guetg et al., 2009).
This may reflect that low amounts of GABAB(1b,2) receptors are
present at glutamatergic terminals. Alternatively, baclofen
A B
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Figure 1. Endogenous GABAB(1a,2) but not GABAB(1b,2) receptors are present in axons and inhibit glutamate release in cultured
hippocampal neurons. A, Representative mEPSC recordings under baseline conditions, during baclofen (100M) application and
after antagonizing GABAB receptors with CGP54626 (1 M) in WT, 1a
/, and 1b/ neurons. Calibration: 20 pA, 25 s.
B, Summary bar graph illustrating that baclofen strongly inhibits the frequency ofmEPSCs inWT (78.1	 3.1%, n
 16) and 1b/
(70.8	 5.1%, n
 15) neurons, but not in 1a/ (7.7	 2.8%, n
 10) neurons. Values aremeans	 SEM, one-sample t test,
*p 0.05, ***p 0.001. C, Cultured hippocampal neurons fromWT, 1a/, and 1b/micewere fixed, permeabilized, and
stained with antibodies recognizing GABAB1a and GABAB1b (GB1), the dendritic marker protein MAP2, or the cytoskeleton protein
tubulin. ArrowsmarkMAP2-negative axons. Note the lack of GB1 immunolabeling in axons of 1a/ neurons. Scale bar, 50m.
D, A:D ratio of the endogenous GABAB1 proteins in WT, 1a
/, and 1b/ neurons. The fluorescence intensity of GB1 immu-
nolabelingwasnormalized to the fluorescence intensity of tubulin immunolabeling. TheA:D ratio of GABAB1 protein is significantly
smaller in 1a/ compared toWT and 1b/neurons (mean	 SEM, ***p 0.001, 1-wayANOVAwith Tukey’s post hoc test).
E, Schematic depiction of endogenous GABAB(1a,2) and GABAB(1b,2) receptor distribution in cultured hippocampal neurons and
hippocampal slice culture. Squares indicate the two in tandem arranged SDs at the N terminus of GABAB1a.
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may also activate somatic GABAB(1b,2)
receptors and the ensuing hyperpolariz-
ing potentials passively propagate to
glutamatergic terminals, where they
contribute to presynaptic inhibition
(Alle and Geiger, 2006).
We next analyzed the expression levels
of the endogenous GABAB1a and GABAB1b
proteins in axons and dendrites of cul-
tured hippocampal neurons. Due to the
lack ofGABAB1a- orGABAB1b-specific an-
tibodies, we used cultured hippocampal
neurons from 1a/ and 1b/mice and
stained them with an antibody recogniz-
ing the common C-term of GABAB1 sub-
units (Kulik et al., 2002). To distinguish
dendrites from axons, we immunolabeled
the dendriticmicrotubule-associated pro-
tein MAP2 and tubulin, a constituent of
axons and dendrites (Caceres et al., 1984).
In WT and 1b/ pyramidal neurons,
GABAB1 immunostainingwas observed in
MAP2-positive somata and dendrites as
well as inMAP2-negative axons (Fig. 1C).
In contrast, in cultured 1a/ pyramidal
neurons, GABAB1 immunostaining was
restricted to the somatodendritic com-
partment. This confirms that primarily
GABAB1a localizes to axons in cultured
pyramidal neurons. To determine the
axon-to-dendrite (A:D) ratio of the en-
dogenous GABAB1 proteins, we normal-
ized the red fluorescence intensity of the
GABAB1 staining to the green fluores-
cence intensity of the tubulin staining in
axons and dendrites. In all three geno-
types the A:D ratio was 1, indicating
that most GABAB1 protein is localized
somatodendritically (WT: 0.54	 0.05, n

7; 1a/: 0.22 	 0.02, n 
 7; 1b/:
0.60	 0.05, n
 8; p 0.001 for 1a/ vs
WT and 1b/). However, the A:D ratio
in 1a/ neurons was significantly re-
ducedcompared toWTand1b/neurons
(Fig. 1D), indicating that significantly more
GABAB1a than GABAB1b protein enters the
axonal compartment. In summary, our
electrophysiological and immunocyto-
chemical analysis demonstrates that cul-
tured pyramidal neurons preserve the
preferential association of GABAB1a with
glutamatergic terminals seen in hip-
pocampal slices (Fig. 1E).
Exogenous GABAB1a and GABAB1b
subunits reproduce the distribution patterns of the
endogenous subunits
We next assessed whether GABAB1 isoforms with an
N-terminal Myc-tag (Myc-GB1a, Myc-GB1b) recapitulate the
subcellular distribution of the endogenous proteins when ex-
pressed in cultured hippocampal neurons. Cultured hippocam-
pal neurons were transfected after 5 d in vitro (DIV5) with
Myc-GB1a or Myc-GB1b cDNAs under control of the neuron-
specific synapsin-1 promoter (Ku¨gler et al., 2001; Boulos et al.,
2006), as this promoter avoids randomization of distribution
patterns due to overexpression (Vigot et al., 2006). To accurately
release the N-terminal Myc-epitope in the Myc-GB1a and Myc-
GB1b proteins, we used a surrogate signal peptide instead of the
intrinsic signal peptides (Ango et al., 1999). We coexpressed
Myc-GB1a orMyc-GB1bwith the freely diffusible red fluorescent
protein (RFP) tdimer2, which outlines the morphology of the
Figure 2. Exogenous GABAB1a but not GABAB1b protein localizes to the axons of transfected hippocampal neurons in culture.
A, Scheme of the tagged GABAB1 isoforms (top). The gray bar indicates the two SDs (SD1, SD2) in GABAB1a, the green bar the
Myc-tag, and black bars the 7 transmembrane domains. Myc-GB1a and Myc-GB1b cDNA expression constructs were individually
cotransfected with a cDNA expression construct encoding soluble RFP. Neurons were fixed at DIV14, permeabilized, and stained
with antibodies recognizingMAP2 (data not shown) or theMyc-tag. Low-magnification images of themerged greenMyc and the
RFP fluorescence are shown at the top. Higher-magnification images of the boxed regions depict axons (arrows) and dendrites
(arrowheads). Scale bars: top, 50m; bottom, 10m.B,When analyzing the totalMyc-GB1a andMyc-GB1b levels in transfected
neurons (Total), the A:D ratio of Myc-GB1a is significantly higher than that of Myc-GB1b (mean	 SEM, **p 0.01, Student’s t
test). Likewise,when analyzingMyc-GB1a andMyc-GB1b at the cell surface of neurons coexpressing exogenous GABAB2 (Surface),
the A:D ratio of Myc-GB1a is significantly higher than that of Myc-GB1b (mean	 SEM, *p 0.05, Student’s t test).
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transfected neurons. Following transfection, neurons were fixed
at DIV14, permeabilized, and stained with antibodies against the
Myc-tag and the dendritic marker MAP2. We found that Myc-
GB1a was present in axons, somata, and dendrites, whereasMyc-
GB1b was restricted to the somatodendritic compartment (Fig.
2A). The A:D ratios of Myc-GB1a and Myc-GB1b were deter-
mined by normalizing the greenMyc fluorescence intensity to the
RFP fluorescence intensity in axons and dendrites (Gu et al.,
2003; Sampo et al., 2003; Das and Banker, 2006). The A:D ratio
for transfectedMyc-GB1a was increased by 2.7-fold compared to
Myc-GB1b (Myc-GB1a: 0.38	 0.04, n

10; Myc-GB1b: 0.14 	 0.05, n 
 10; p 
0.01) (Fig. 2B), analogous as with the en-
dogenous GABAB1a and GABAB1b pro-
teins in 1b/ and 1a/ neurons,
respectively (Fig. 1D). This demonstrates
that the trafficking of endogenous and
transfected GABAB1 subunits is alike.
Moreover, this indicates that neither pu-
tative compensatory mechanisms in the
knock-out backgrounds nor the surrogate
signal peptide interfere with trafficking.
We nevertheless also determined the
distribution patterns of GABAB1 pro-
teins that are C-terminally tagged with
the green fluorescent protein (GFP) and
therefore contain their intrinsic signal
peptides. The A:D ratio for GB1a-GFP
was significantly increased by twofold
compared to GB1b-GFP (GB1a-GFP:
0.49 	 0.06, n 
 7; GB1b-GFP: 0.25 	
0.04, n 
 7; p  0.01), thus consolidat-
ing that the surrogate signal peptide and
the intrinsic signal peptides lead to a
comparable axonal versus dendritic dis-
tribution. Furthermore, we analyzed
whether trafficking is influenced by the
developmental stage of cultured neu-
rons. In neurons at DIV21, the A:D ratio
of Myc-GB1a was significantly in-
creased compared to Myc-GB1b (Myc-
GB1a: 0.49 	 0.04, n 
 6; Myc-GB1b:
0.25 	 0.05, n 
 6; p  0.01) (supple-
mental Fig. S1, available at www.jneurosci.
org as supplementalmaterial), providingno
evidence for a developmental regulation of
trafficking.
The levels of Myc-GB1a and Myc-
GB1b at the cell surface were too low for
reliable quantification. Presumably, exog-
enousGABAB1 subunits competewith en-
dogenous GABAB1 subunits for GABAB2,
which is required for escorting GABAB1 to
the plasmamembrane (Margeta-Mitrovic
et al., 2000; Pagano et al., 2001). To in-
crease surface expression levels of the ex-
ogenous GABAB1 proteins, we therefore
coexpressed the GABAB2 protein with the
individual Myc-GB1a and Myc-GB1b
proteins. This allowed quantification of
the Myc-fluorescence at the cell surface
of nonpermeabilized cells. The Myc-
fluorescence was normalized to the fluo-
rescence of coexpressed RFP and the A:D ratio determined as
described above. Surface Myc-GB1a exhibited a significantly in-
creased A:D ratio compared to surface Myc-GB1b (Myc-GB1a:
0.50	 0.09,n
 10;Myc-GB1b: 0.26	 0.02,n
 10; p 0.05) (Fig.
2B), demonstrating that GABAB1a is also enriched over GABAB1b
at the axonal plasma membrane. In addition, comparison of
the data in Figure 2B shows that significantly more GABAB1a
than GABAB1b protein traffics to axons, regardless of whether
or not exogenous GABAB2 is supplied to WT neurons. This
demonstrates that the GABAB2 expression level does not
A
B
C D
Figure 3. The SDs in GABAB1a mediate axonal localization. A, In Myc-GB1aCS, the disulfide bridges in the SDs, which are critical for
ligand binding (Kirkitadze and Barlow, 2001), were disrupted by mutation of cysteines to serines. Myc-GB1a and Myc-GB1aCS were
individually coexpressedwith RFP in cultured hippocampal neurons. Neuronswere fixed at DIV14, permeabilized, and stainedwith anti-
bodies recognizingMAP2 (datanot shown) and theMyc-tag.Merged images of thegreenMyc and theRFP fluorescence are shownat the
top.Note thatMyc-GB1aCS isexcluded fromaxons. Scalebar, 10m.B,Myc-GB1aSD1andMyc-GB1aSD2proteins lackingeitherSD1
orSD2,respectively,bothlocalizetoaxonsanddendritesoftransfectedhippocampalneurons.MergedimagesofthegreenMycandtheRFP
fluorescenceareshownatthetop.Scalebar,10m.C, TheA:DratioofMyc-GB1aCS issignificantly reducedcomparedtothatofMyc-GB1a,
while no significant reduction in the A:D ratios was observed for Myc-GB1aSD1 and Myc-GB1aSD2 (mean	 SEM, ***p 0.001,
1-wayANOVA, Tukey’spost hoc test).D,Myc-GB1aCSandMyc-GB1a,whenexpressed togetherwithGABAB2, activateKir3.1/3.2 channels
in transfected CHO cells to a similar extent. Calibration: 50 pA, 5 s.
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markedly influence the axonal versus
dendritic distribution of the GABAB1a
and GABAB1b proteins.
GABAB2 needs to coassemble with
GABAB1a to traffic to the
axonal compartment
We conversely investigated whether the
subcellular localization of GABAB2 is in-
fluenced by the GABAB1 subunit iso-
forms. We analyzed the axonal versus
dendritic distribution of transfected
Myc-GB2 in WT as well as in 1a/ and
1b/ neurons. Myc-GB2 failed to effi-
ciently traffic into axons in neurons of all
genotypes, which is reflected by the
similar A:D ratios (Myc-GB2 in WT:
0.31	 0.08, n
 10; Myc-GB2 in 1a/:
0.32	 0.04, n
 10; Myc-GB2 in 1b/:
0.29 	 0.03, n 
 10; p  0.05). Presum-
ably, the amount of endogenous GABAB1a
protein is insufficient for efficient traffick-
ing ofMyc-GB2 into axons. Coexpression
of exogenous Myc-GB1a but not Myc-
GB1b significantly increased the A:D ratio
of HA-GB2 in WT neurons (HA-GB2 
Myc-GB1a: 0.59 	 0.10, n 
 6; HA-GB2
 Myc-GB1b: 0.21 	 0.05, n 
 6; p 
0.01). This indicates that GABAB2 is a
somatodendritic protein that needs to
coassemble with GABAB1a to reach the
axonal compartment.
Each SD in GABAB1a canmediate
axonal localization on its own
The SDs in GABAB1a bind with low nano-
molar affinity to binding sites in neuronal
membranes (Tiao et al., 2008) and likely
mediate axonal localization through in-
teraction with other protein(s). To inter-
act with binding partners the SDs in
GABAB1a need to fold into a globular
structure that is stabilized by disulfide
bonds (Wei et al., 2001; Tiao et al., 2008).
We therefore addressed whether the ter-
tiary structure of the SDs is crucial for
axonal localization of GABAB1a. In the
Myc-GB1aCS mutant, we prevented di-
sulfide bond formation in each of the SDs
by converting two of the four conserved
cysteines into serines. Following transfec-
tion into cultured hippocampal neurons,
Myc-GB1aCS was robustly targeted to
dendrites but not to axons (Fig. 3A). Ac-
cordingly, the A:D ratio in Myc-GB1aCS
was significantly smaller than that for WT Myc-GB1a (Myc-
GB1a: 0.41	 0.06, n
 8;Myc-GB1aCS: 0.14	 0.03, n
 10; p
0.001) (Fig. 3C). Of note, the A:D ratio of Myc-GB1aCS was
similar to that ofMyc-GB1b (Fig. 2B).WhileMyc-GB1aCS failed
to traffic to axons the mutant protein efficiently activated Kir3
channels when coexpressedwithGABAB2 (Fig. 3D). This demon-
strates that interfering with the folding of the SDs impairs axonal
trafficking without impairing receptor surface expression or
G-protein signaling. Altogether, these results support that the
SDs engage in interactions that are necessary for axonal localiza-
tion of GABAB1a.
Structurally, the two SDs in GABAB1a differ from each other
(Blein et al., 2004). The first SD shows conformational heteroge-
neity under a wide range of conditions and interacts with the
extracellular matrix protein fibulin-2. The second SD is more
compactly folded and exhibits strong structural similarity
Figure4. The SDs of GABAB1a function as axonal targeting signals in theheterologous CD8protein. InMyc-SDs-CD8, the SDs
of GABAB1a were fused to the extracellular N-terminal domain of CD8. Myc-CD8 or Myc-SDs-CD8 were individually coex-
pressed with RFP in cultured hippocampal neurons. Neurons were fixed at DIV14, permeabilized, and stained with antibodies
recognizingMAP2 (datanot shown)or theMyc-tag.Merged imagesof greenMycandRFP fluorescenceare shownon top.Note that
Myc-SDs-CD8 is barely detectable in dendrites, but highly expressed in axons. Scale bar, 10m.
A
B
Figure 5. The SDs of GABAB1a redirect the somatodendritic mGluR1a protein to axons. A, In Myc-SDs-mGluR1a, the two SDs of
GABAB1a were fused to the extracellular N-terminal domain of mGluR1a. Myc-mGluR1a and Myc-SDs-mGluR1a were individually
coexpressedwithRFP in culturedhippocampal neurons. Neuronswere fixed atDIV14, permeabilized, and stainedwith anantibody
recognizing theMyc-tag. Arrows indicate the axon, arrowheads the dendrites. Note thatMyc-SDs-mGluR1a but notMyc-mGluR1a
is expressed in the axon. Scale bar, 25m. B, Sections of axons and dendrites of neurons expressingMyc-mGluR1a andMyc-SDs-
mGluR1a. Merged images of green Myc and RFP fluorescence are shown on top. Scale bar, 10m.
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with the SDs in proteins of the complement system. It is con-
ceivable that the two SDs exert different functions and interact
with different proteins. We therefore investigated whether
each of the two SDs in GABAB1a can mediate axonal targeting
on its own. In the Myc-GB1aSD1 and Myc-GB1aSD2 mu-
tants, we deleted either the first or the second SD, respectively
(Fig. 3B). Myc-GB1aSD1 and Myc-GB1aSD2 were both
efficiently targeted to axons, and the A:D ratios were not sig-
nificantly different from that of WT Myc-GB1a (Myc-GB1a:
0.41 	 0.06, n 
 8; Myc-GB1aSD1: 0.49 	 0.04, n 
 9;
Myc-GB1aSD2: 0.47	 0.04, n
 8; p 0.05) (Fig. 3C). This
shows that each of the two SDs in GABAB1a canmediate axonal
localization on its own.
The SDs of GABAB1a polarize the uniformly distributed
transmembrane protein CD8 to axons
The SDs could promote axonal localization of GABAB1a either by
acting as axonal trafficking signals or, alternatively, by inactivat-
ing dendritic targeting signals, which would also result in a more
uniform distribution. To distinguish between these two possibil-
ities, we analyzed whether the SDs of GABAB1a are capable of
polarizing an unpolarized heterologous transmembrane protein,
CD8 (Jareb and Banker, 1998), to axons. We first confirmed
that Myc-CD8 uniformly distributes to axons and dendrites of
transfected hippocampal neurons (Fig. 4). As expected for an
unpolarized protein, the A:D ratio was with 1.24	 0.07 (n
 24)
close to 1. In contrast, when the two SDs of GABAB1a were fused
to the ectodomain of CD8, the chimeric Myc-SDs-CD8 pro-
tein clearly polarized to axons (A:D ratio 2.37	 0.26, n
 24; p
0.001 vs Myc-CD8) (Fig. 4). This clearly identifies the SDs as
bona fide axonal targeting signals.
The SDs of GABAB1a direct the somatodendritic mGluR1a
protein to axons
According to our hypothesis, the SDs of GABAB1a not only act
as axonal trafficking signals but also override the dendritic
targeting signals present in GABAB1a and/or GABAB2. We
therefore investigated whether the SDs of GABAB1a can direct
a somatodendritically localized heterologous transmembrane
protein to axons. For this experiment, we usedmGluR1a, a receptor
with C-terminal dendritic trafficking signals (Francesconi and
Duvoisin, 2002; Das and Banker, 2006). We confirmed that
Myc-mGluR1a is highly expressed in the dendrites but ex-
cluded from the axons of transfected
hippocampal neurons (Fig. 5A,B).
When the two SDs of GABAB1a were
fused to the N-terminal ectodomain of
mGluR1a, the chimeric Myc-SDs-
mGluR1a protein readily trafficked to
axons and exhibited a significantly
higher A:D ratio than WT Myc-
mGluR1a (Myc-mGluR1a: 0.03 	 0.06,
n
 9; Myc-SDs-mGluR1a: 1.26	 0.15,
n 
 11; p  0.001). This shows that the
SDs of GABAB1a can override the soma-
todendritic targeting signals in the C
terminus of mGluR1a.
Surface expression is not required for
axonal delivery of GABAB1a
GABAB1a is not only present in the axons,
but also highly expressed in the somato-
dendritic compartment (Figs. 1, 2). It is
therefore conceivable that GABAB1a reaches the axonal com-
partment through transcytosis from the somatodendritic com-
partment, similar to what is reported for the neuronal cell
adhesion molecule NgCAM (Wisco et al., 2003). This dendrite-to-
axon transcytotic pathway requires internalization of axonally
bound proteins from the dendritic plasmamembrane.We inves-
tigated whether Myc-GB1a can be transported into axons in the
absence of surface expression. Since GABAB2 is necessary for sur-
face localization of GABAB1 subunits (Margeta-Mitrovic et al.,
2000; Pagano et al., 2001), we prevented surface trafficking of
Myc-GB1a by expressing it in cultured hippocampal neurons of
GABAB2
/ (2/) mice (Gassmann et al., 2004). Myc-GB1a
was transported into axons in the absence of GABAB2 (Fig. 6) and
the A:D ratio in 2/ neurons was not significantly different
from that inWTneurons (Myc-GB1a inWT: 0.45	 0.05, n
 12;
Myc-GB1a in 2/: 0.40	 0.04, n
 19; p 0.05). This corrob-
orates that Myc-GB1a reaches the axonal compartment via an
intracellular route, independent of any surface expression. Lat-
eral diffusion of surface receptors is therefore not necessary for
axonal localization of GABAB1a. However, the SDs are not only
involved in axonal delivery of GABAB receptors but also in their
retention at the cell surface of the terminal (Tiao et al., 2008).
Lateral diffusion and selective retention could therefore, in prin-
ciple, contribute to the pool of axonal GABAB1a receptors. It was
recently proposed that proteins not only traffic into axons via
post-Golgi transport vesicles but also within the endoplasmic
reticulum (ER), from where proteins are released via exit sites
(Aridor and Fish, 2009; Merianda et al., 2009). It is therefore
conceivable that GABAB1a traffics into axons within the ER. As
previously reported (Ramírez et al., 2009), we found a partial
colocalization of transfectedGABAB1a subunits with the ER in the
somatodendritic compartment using an ER-targeted GFP (Aoki
et al., 2002) as a marker (supplemental Fig. S2, available at www.
jneurosci.org as supplemental material). We also observed a par-
tial colocalization of transfected GABAB1a with ER-targeted GFP
in axons, making it conceivable that some GABAB1a also enters
axonal ER. However, according to prevailing concepts axonally
destined proteins traffic in intracellular post-Golgi transport ves-
icles to the terminals (Horton and Ehlers, 2003). We therefore
expect that intracellular GABAB1a in axons is mostly present in
transport vesicles delivering their cargo to the terminal.
Figure 6. Surface expression is not required for axonal trafficking of GABAB1a. Axonal and dendritic sections of cultured WT or
GABAB2
/ (2/) hippocampal neurons expressing Myc-GB1a and RFP. Neurons were fixed at DIV14, permeabilized, and
stainedwith antibodies recognizingMAP2 (data not shown) or theMyc-tag.Merged images of greenMyc andRFP fluorescence are
shown on top. Scale bar, 10m.
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Discussion
The SDs of GABAB1a are axonal targeting signals
Wepreviously reported that selectively theGABAB1a protein traf-
fics into the axons of pyramidal neurons in organotypic slice
cultures, while both the GABAB1a and GABAB1b proteins traffic
into dendrites (Vigot et al., 2006). The reason for this difference
in axonal trafficking is not obvious. GABAB1a only differs from
GABAB1b by the presence of a pair of SDs at its N terminus. A
classical scenario whereby GABAB1b traffics to the dendrites by
unique C-terminal dendritic targeting signal(s) and GABAB1a
distributesmore uniformly due to the absence of such signal(s) is
therefore ruled out. A plausible hypothesis is that GABAB1a and
GABAB1b are retained in the somatodendritic compartment by
common dendritic targeting signal(s) in GABAB1 and/or the as-
sociated GABAB2 subunit. A fraction of GABAB1a protein would
then be directed to axons by dominant axonal targeting signal(s)
or signals that inactivate the dendritic signal(s), whichwould also
result in amore randomized distribution.We now report that the
SDs in GABAB1a function as bona fide axonal targeting signals.
When fused to the extracellular/luminal domain of CD8 the
SDs efficiently polarize this prototypical unpolarized protein
(Jareb and Banker, 1998) to axons. Likewise, when fused to
mGluR1a the SDs direct this somatodendritic protein to axons,
directly showing that the SDs can override C-terminal dendritic
targeting signals (Francesconi and Duvoisin, 2002; Das and
Banker, 2006). SDs are also present in other neuronal proteins,
for example in the “CUB and sushi multiple domains 1”
(CSMD1) and Sez-6 proteins. CSMD1 is a membrane compo-
nent of the distal tip of growing axons (Kraus et al., 2006). It
remains an interesting possibility that SDs mediate the axonal
localization of this protein. The Sez-6 protein isoforms are pre-
dominantly expressed in the somatodendritic compartment but
also present at the axon terminal (Gunnersen et al., 2007). Traf-
ficking of Sez-6 proteins to axons could therefore also depend on
the SDs and involve amechanism that overrides dendritic signals,
in the same way as now proposed for GABAB1a.
We show that the tertiary structure of the SDs is critical for
axonal localization of GABAB1a. Since the SDs of GABAB1a rec-
ognize binding sites in neuronal membranes (Tiao et al., 2008),
they probably engage in interactions that direct axonal localiza-
tion. Our observation that each of the two SDs mediates axonal
localization on its own suggests that they interact with proteins of
similar function or with binding sites within the same protein.
The SDs confer axonal localization in the absence of GABAB1a
surface expression, suggesting that they bind to axonally destined
proteins in the lumen of the trans-Golgi network (TGN). Such a
mechanism for axonal targeting has been suggested for NgCAM,
which uses five fibronectin type-III like repeats in its ectodomain
as targeting signals (Sampo et al., 2003). It was recently proposed
that the elements of a mature presynaptic terminal, e.g., calcium
channel subunits, endocytic proteins and synaptic vesicle pro-
teins are transported along axons as discrete “transport packets”
(Ahmari et al., 2000). Since GABAB receptors are localized near
the active zone (Kulik et al., 2003) it is plausible that GABAB1a is
transported “piggyback style” by interacting with presynaptic
proteins in the lumen of transport vesicles, similar to other ax-
onally destined proteins (Roos and Kelly, 2000). Since GABAB1a
partially colocalizes with ER-targeted GFP in the axons, it is pos-
sible that someGABAB1a protein also reaches the axon within the
ER (Aridor and Fish, 2009; Merianda et al., 2009). This would
imply the existence of a SD-dependent mechanism that selec-
tively distributes GABAB1a but not GABAB1b to the axonal ER. It
is interesting to note that functionally relevant binding sites for
the SDs in GABAB1a also exist at the cell surface of glutamatergic
terminals (Tiao et al., 2008). It remains to be seen whether these
extracellular binding sites are identical with the intracellular
binding sites regulating axonal trafficking.
Our model for the differential targeting of GABAB1 isoforms
proposes the existence of dendritic targeting signals in the
GABAB1 and/or GABAB2 subunits. Dendritic targeting signals in
transmembrane proteins are generally confined to cytoplasmic
domains (West et al., 1997; Jareb andBanker, 1998; Poyatos et al.,
2000; Rivera et al., 2003; Hirokawa and Takemura, 2005). Both
the C-terminal domain of the GABAB1 and GABAB2 subunits
contain a number of putative dendritic targeting signals. It was
recently proposed that GABAB1 and GABAB2 subunits are trans-
ported into dendrites while still residing in the ER and before
assembly into heteromeric complexes (Vidal et al., 2007; Ramírez
et al., 2009). Consistent with this proposal, we found a colocal-
ization of transfected GABAB1 protein with ER-targeted GFP.
Possibly, GABAB1 and GABAB2 subunits do not require dendritic
targeting signals in their primary sequence if transported to den-
drites within the ER.
Conditional activation of axonal and somatodendritic
targeting signals can explain GABAB receptor distribution
Our observation that GABAB1a is transported into axons without
preceding cell surface expression rules out selective retention at
the plasma membrane and dendrite-to-axon transcytosis as the
mechanism for axonal localization (Wisco et al., 2003). Overall,
our findings are most compatible with the “selective delivery”
model for axonal trafficking (Horton and Ehlers, 2003; Sampo et
al., 2003;Wisco et al., 2003). In thismodel both the GABAB1a and
GABAB1b subunits are transported into dendrites in somatoden-
dritic post-Golgi carriers. Additionally, some GABAB1a subunits
are transported to axons in distinct axonal carriers. Somatoden-
dritic targeting signals, residing within the C-terminal domain of
GABAB1 and/or GABAB2, would sort GABAB1a to the default so-
matodendritic compartment unless the SDs bind to axonally des-
tined protein(s) in the lumen of the TGN. The availability of this
putative SD-binding protein(s) would represent a limiting factor
for sorting of GABAB1a into axonal transport carriers and explain
whymuch of theGABAB1a protein resides in the somatodendritic
compartment. A prerequisite for the “selective delivery”model is
that the luminal SDs can silence dendritic targeting signal(s) in
GABAB1a and/or GABAB2 on the opposite side of the membrane.
Our experiments with mGluR1a directly show that luminal SDs
can inactivate somatodendritic targeting signals across the mem-
brane, suggesting that they function similarly in the structurally
relatedGABAB receptors. Of note, conformational changes in the
extracellular domain ofGABAB1 are allosterically coupled to con-
formational changes in the intracellular domains of GABAB1 and
GABAB2 (Parmentier et al., 2002). This could explain how bind-
ing to the SDs leads to the unbinding of dendritic sorting adap-
tors across the membrane. Of physiological relevance, the
conditional activation of axonal trafficking signals may provide a
means to adjust the strength of presynaptic GABAergic inhibi-
tion. Finally, on a different note, the SDs of GABAB1a are a po-
tentially useful experimental tool for delivering transmembrane
proteins to axons.
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